Infectious clone-derived viruses from virulent and vaccine strains of porcine reproductive and respiratory syndrome virus mimic biological properties of their parental viruses in a pregnant sow model

Byungjoon Kwon, Israrul H. Ansari, Fernando A. Osorio, Asit K Pattnaik

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Understanding of the molecular basis of virulence and attenuation of porcine reproductive and respiratory syndrome virus (PRRSV) is important for the development of a safe and efficacious vaccine. Prime Pac (PP) is an attenuated vaccine strain of PRRSV which is being used in our laboratories as a source of gene(s) for the generation of chimeric constructs in the background of a highly virulent PRRSV derived from an infectious clone (FL12) to examine the molecular determinants of virulence and attenuation. To facilitate these studies, we generated a full-length cDNA clone of the PP vaccine strain by serially replacing the genomic fragments of the FL12 with the corresponding regions from the PP strain. The virus rescued from this newly assembled cDNA clone (PP18) exhibited in vitro growth properties and in vivo apathogenic characteristics of the parental PP virus. Using pregnant sows as the experimental model of reproductive pathogenesis, we have been able to unequivocally demonstrate the clearly contrasting phenotypes of the virulent and the attenuated viruses derived from the infectious clones (FL12 and PP18). The development of an infectious clone derived from a bona fide attenuated PRRSV vaccine strain should significantly facilitate ongoing studies to determine the molecular basis of virulence and attenuation.

Original languageEnglish (US)
Pages (from-to)7071-7080
Number of pages10
JournalVaccine
Volume24
Issue number49-50
DOIs
StatePublished - Nov 30 2006

Fingerprint

Porcine respiratory and reproductive syndrome virus
Porcine reproductive and respiratory syndrome virus
sows
Vaccines
Clone Cells
clones
vaccines
Viruses
viruses
Virulence
virulence
Complementary DNA
Attenuated Vaccines
live vaccines
Theoretical Models
pathogenesis
Phenotype
genomics
phenotype
Growth

Keywords

  • PRRSV
  • Pregnant sow model
  • Prime Pac
  • Reverse genetics
  • Vaccine

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Infectious clone-derived viruses from virulent and vaccine strains of porcine reproductive and respiratory syndrome virus mimic biological properties of their parental viruses in a pregnant sow model. / Kwon, Byungjoon; Ansari, Israrul H.; Osorio, Fernando A.; Pattnaik, Asit K.

In: Vaccine, Vol. 24, No. 49-50, 30.11.2006, p. 7071-7080.

Research output: Contribution to journalArticle

@article{c244cc156ed84e258bf8337276da33ce,
title = "Infectious clone-derived viruses from virulent and vaccine strains of porcine reproductive and respiratory syndrome virus mimic biological properties of their parental viruses in a pregnant sow model",
abstract = "Understanding of the molecular basis of virulence and attenuation of porcine reproductive and respiratory syndrome virus (PRRSV) is important for the development of a safe and efficacious vaccine. Prime Pac (PP) is an attenuated vaccine strain of PRRSV which is being used in our laboratories as a source of gene(s) for the generation of chimeric constructs in the background of a highly virulent PRRSV derived from an infectious clone (FL12) to examine the molecular determinants of virulence and attenuation. To facilitate these studies, we generated a full-length cDNA clone of the PP vaccine strain by serially replacing the genomic fragments of the FL12 with the corresponding regions from the PP strain. The virus rescued from this newly assembled cDNA clone (PP18) exhibited in vitro growth properties and in vivo apathogenic characteristics of the parental PP virus. Using pregnant sows as the experimental model of reproductive pathogenesis, we have been able to unequivocally demonstrate the clearly contrasting phenotypes of the virulent and the attenuated viruses derived from the infectious clones (FL12 and PP18). The development of an infectious clone derived from a bona fide attenuated PRRSV vaccine strain should significantly facilitate ongoing studies to determine the molecular basis of virulence and attenuation.",
keywords = "PRRSV, Pregnant sow model, Prime Pac, Reverse genetics, Vaccine",
author = "Byungjoon Kwon and Ansari, {Israrul H.} and Osorio, {Fernando A.} and Pattnaik, {Asit K}",
year = "2006",
month = "11",
day = "30",
doi = "10.1016/j.vaccine.2006.07.010",
language = "English (US)",
volume = "24",
pages = "7071--7080",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "49-50",

}

TY - JOUR

T1 - Infectious clone-derived viruses from virulent and vaccine strains of porcine reproductive and respiratory syndrome virus mimic biological properties of their parental viruses in a pregnant sow model

AU - Kwon, Byungjoon

AU - Ansari, Israrul H.

AU - Osorio, Fernando A.

AU - Pattnaik, Asit K

PY - 2006/11/30

Y1 - 2006/11/30

N2 - Understanding of the molecular basis of virulence and attenuation of porcine reproductive and respiratory syndrome virus (PRRSV) is important for the development of a safe and efficacious vaccine. Prime Pac (PP) is an attenuated vaccine strain of PRRSV which is being used in our laboratories as a source of gene(s) for the generation of chimeric constructs in the background of a highly virulent PRRSV derived from an infectious clone (FL12) to examine the molecular determinants of virulence and attenuation. To facilitate these studies, we generated a full-length cDNA clone of the PP vaccine strain by serially replacing the genomic fragments of the FL12 with the corresponding regions from the PP strain. The virus rescued from this newly assembled cDNA clone (PP18) exhibited in vitro growth properties and in vivo apathogenic characteristics of the parental PP virus. Using pregnant sows as the experimental model of reproductive pathogenesis, we have been able to unequivocally demonstrate the clearly contrasting phenotypes of the virulent and the attenuated viruses derived from the infectious clones (FL12 and PP18). The development of an infectious clone derived from a bona fide attenuated PRRSV vaccine strain should significantly facilitate ongoing studies to determine the molecular basis of virulence and attenuation.

AB - Understanding of the molecular basis of virulence and attenuation of porcine reproductive and respiratory syndrome virus (PRRSV) is important for the development of a safe and efficacious vaccine. Prime Pac (PP) is an attenuated vaccine strain of PRRSV which is being used in our laboratories as a source of gene(s) for the generation of chimeric constructs in the background of a highly virulent PRRSV derived from an infectious clone (FL12) to examine the molecular determinants of virulence and attenuation. To facilitate these studies, we generated a full-length cDNA clone of the PP vaccine strain by serially replacing the genomic fragments of the FL12 with the corresponding regions from the PP strain. The virus rescued from this newly assembled cDNA clone (PP18) exhibited in vitro growth properties and in vivo apathogenic characteristics of the parental PP virus. Using pregnant sows as the experimental model of reproductive pathogenesis, we have been able to unequivocally demonstrate the clearly contrasting phenotypes of the virulent and the attenuated viruses derived from the infectious clones (FL12 and PP18). The development of an infectious clone derived from a bona fide attenuated PRRSV vaccine strain should significantly facilitate ongoing studies to determine the molecular basis of virulence and attenuation.

KW - PRRSV

KW - Pregnant sow model

KW - Prime Pac

KW - Reverse genetics

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=33846198410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846198410&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2006.07.010

DO - 10.1016/j.vaccine.2006.07.010

M3 - Article

VL - 24

SP - 7071

EP - 7080

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 49-50

ER -